human | Q5 |
P496 | ORCID iD | 0000-0001-6064-7584 |
P1153 | Scopus author ID | 6507801715 |
P69 | educated at | University of Caen Normandy | Q568554 |
P108 | employer | Spanish National Research Council | Q1024362 |
P735 | given name | Jose | Q19801116 |
Jose | Q19801116 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q45141104 | 2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo |
Q102058717 | A Zic2-regulated switch in a noncanonical Wnt/βcatenin pathway is essential for the formation of bilateral circuits |
Q112283168 | A protocol to extract cell-type-specific signatures from differentially expressed genes in bulk-tissue RNA-seq |
Q48300446 | Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory. |
Q40511087 | Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling |
Q42776070 | Blocking miRNA Biogenesis in Adult Forebrain Neurons Enhances Seizure Susceptibility, Fear Memory, and Food Intake by Increasing Neuronal Responsiveness. |
Q41816299 | Brain size regulations by cbp haploinsufficiency evaluated by in-vivo MRI based volumetry |
Q38255593 | Can changes in histone acetylation contribute to memory formation? |
Q93010827 | Cbp-dependent histone acetylation mediates axon regeneration induced by environmental enrichment in rodent spinal cord injury models |
Q48019445 | Development and maintenance of the brain's immune toolkit: Microglia and non-parenchymal brain macrophages |
Q93101141 | Ecdysone-Induced 3D Chromatin Reorganization Involves Active Enhancers Bound by Pipsqueak and Polycomb |
Q35704593 | Equivocal roles of tissue-type plasminogen activator in stroke-induced injury |
Q38138763 | Histone H3 lysine methylation in cognition and intellectual disability disorders. |
Q39460830 | Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome. |
Q40567601 | Is tissue-type plasminogen activator a neuromodulator? |
Q38873330 | Lack of IL-1R8 in neurons causes hyperactivation of IL-1 receptor pathway and induces MECP2-dependent synaptic defects |
Q47107067 | Loss of Kdm5c Causes Spurious Transcription and Prevents the Fine-Tuning of Activity-Regulated Enhancers in Neurons. |
Q48654868 | Loss of neuronal 3D chromatin organization causes transcriptional and behavioural deficits related to serotonergic dysfunction |
Q38085375 | Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders. |
Q48260264 | Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects |
Q112713981 | SFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation |
Q112284132 | Secondary loss of miR-3607 reduced cortical progenitor amplification during rodent evolution |
Q43281713 | Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. |
Q45293177 | Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes. |
Q46739636 | The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo |
Q46455334 | Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis |
Q48487420 | Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity |
Q46268137 | Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity. |
Search more.